Development of Vitiligo during Treatment with Adalimumab: A Plausible or Paradoxical Response?

Jung JM, Lee YJ, Won CH, Chang SE, Lee MW, Choi JH, Moon KC. Development of Vitiligo during Treatment with Adalimumab: A Plausible or Paradoxical Response? Ann Dermatol. 2015 Oct; 27(5):620-1.

View in: PubMed

authors with profiles

Kee Moon

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support